Meto vs. Brello: Which Metabolic Health Platform is Right for You?
What is Brello and What is Meto?
Brello is a digital health platform focused on women’s hormonal health, particularly during perimenopause and menopause. Its primary offering includes symptom tracking, virtual consults with women’s health practitioners, educational resources, and support for hormone replacement therapy (HRT). Brello is designed to help women manage symptoms like hot flashes, mood swings, sleep issues, and weight gain associated with hormonal shifts. While Brello does address some metabolic factors, its core emphasis is on hormone health and lifestyle guidance rather than comprehensive weight care or chronic condition management.
Meto, by contrast, is a doctor-led metabolic health platform that delivers end-to-end medical care for weight, hormones, and long-term health. It’s built for people dealing with complex metabolic challenges — including PCOS, insulin resistance, and age-related decline — and offers a more clinically intensive approach than Brello. Instead of focusing only on symptom management, Meto addresses the root biological causes using lab diagnostics, GLP-1 medications, AI-powered monitoring, and ongoing care from physicians and health coaches. It’s insurance-compatible and designed to support not just symptom relief, but total metabolic restoration.
| Features | Meto | Brello |
|---|---|---|
| Approach to Care | Medical-led, personalized metabolic and hormonal care. | Hormone health support and symptom tracking for women in midlife. |
| Use of Technology | AI-powered health insights, telehealth, lab & device integration. | Symptom tracking and telehealth for HRT support. |
| Insurance Coverage | Accepts most major insurance providers. | Not currently insurance-covered; out-of-pocket model. |
| Pricing Model | Copay-based, insurance-eligible; transparent costs. | Monthly membership fee with optional add-ons. |
| Clinical Team Availability | Physicians, NPs, endocrinologists, coaches, and dietitians. | Women’s health practitioners, HRT specialists. |
| Availability | U.S. (expanding). | U.S. only. |
| Program Flexibility | Fully personalized, adjusts to metabolic and hormonal needs. | Tailored to menopausal symptom profile. |
| Patient Support | Dedicated care team with medical and lifestyle coaching. | Asynchronous communication with care team. |
| Mobile & Web Experience | Mobile & web apps with lab data, wearables, and insights. | App with symptom tracking, resources, and messaging. |
| Community and Peer Support | Clinically moderated groups and virtual educational events. | Peer support forums and educational content. |
Core Philosophy & Approach
Brello approaches care through the lens of hormone health, aiming to help women feel more in control of their midlife symptoms. Its model is focused on relief: helping users identify patterns, connect with care providers, and manage their hormonal transitions more comfortably. It uses a combination of symptom logging, coaching, and optional HRT to help manage issues like fatigue, weight changes, or mood fluctuations. The goal is to provide ease, comfort, and empowerment, not to overhaul metabolic function.
Meto, however, takes a deeper biological approach. It starts with the belief that weight, fatigue, and hormonal shifts are not just inevitable parts of aging — they are signals of underlying metabolic dysfunction that can be addressed through clinical care. Meto integrates diagnostics, expert-guided care plans, and data from labs and devices to offer long-term solutions for people whose symptoms go beyond just menopause. Its focus is not only to relieve discomfort, but to reverse underlying drivers like insulin resistance or chronic inflammation to help patients live healthier, longer.
Medical Supervision & Expertise
Brello offers virtual consults with women’s health practitioners, primarily for education, hormone symptom guidance, and potential prescriptions for HRT. While its providers are knowledgeable in midlife care, the platform does not offer integrated medical treatment for conditions like PCOS, diabetes, or obesity. HRT is discussed as an option, but metabolic testing, labs, and chronic disease care are not central to the Brello model. Meto was designed from the ground up as a clinical weight care and metabolic health platform. Users begin with medical intake, lab tests, and physician consultation — and remain under medical supervision throughout their care journey. The team includes doctors, dietitians, health coaches, and specialists in endocrinology and obesity medicine. Patients receive continuous care, not just a one-time prescription or check-in. If medications like GLP-1s are used, they are prescribed within a broader clinical strategy, alongside nutrition support, behavior change tools, and close monitoring.
Personalization of Care
Personalization within Brello is based primarily on the symptoms reported by the user. Based on this input, users receive tailored recommendations for supplements, lifestyle changes, or potential prescriptions. While this approach can help address discomfort and support daily wellbeing, it does not include lab-based customization or monitoring of metabolic data like insulin, glucose trends, or inflammatory markers.
Meto personalizes every step of the care journey using clinical data, lab results, wearable inputs, and real-time monitoring. Plans evolve as the user’s body does — from titrating medications to adjusting nutrition strategies or focusing on specific hormones like cortisol or thyroid. Personalization isn’t just a feature — it’s foundational. Whether the goal is to reduce visceral fat, manage symptoms of insulin resistance, or improve energy, Meto adapts care to the whole person, with biology in focus.
Prescription Medication & GLP-1 Access
Brello offers some medication guidance, primarily around hormone replacement therapy (HRT) for perimenopausal and menopausal symptoms. However, it does not currently offer GLP-1s (like Ozempic or Mounjaro) as part of its care model and does not focus on pharmacological support for metabolic conditions.
Meto includes prescription support as part of an integrated care plan. Patients may be eligible for GLP-1 medications after proper medical assessment, labs, and provider consultation. But medication is never the endpoint — it’s one component of a complete program. Meto supports patients before, during, and after medication usage, including deprescription support. This comprehensive approach ensures that GLP-1s are not used in isolation, but alongside nutrition, labs, coaching, and long-term health tracking.
Which Platform Should You Choose? Who Are They For?
Brello is best suited for women entering perimenopause or menopause who are looking for education, support, and symptom relief in a non-intimidating format. It’s great for users seeking help with hot flashes, sleep changes, or mood swings, and who want to explore HRT or natural alternatives with professional guidance. If your primary goal is to feel more in control of midlife symptoms without diving into full-scale metabolic care, Brello may be a comfortable, focused option.
Meto is built for people who need more than symptom tracking. If you’ve struggled with unexplained weight gain, fatigue, insulin resistance, hormonal imbalances, or you’re not getting results with general lifestyle changes — Meto offers an evidence-based, medical solution. It’s especially effective for those with PCOS, prediabetes, metabolic syndrome, or those navigating menopause with deeper metabolic concerns. With expert guidance, clinical oversight, and long-term support, Meto helps you take charge of your biology — not just your symptoms.
